2024 annual financial data
Takeda Pharmaceutical 2024 Operating margin
Direct answer
Operating margin was 5.02%.
Operating income was 214,075,000,000 JPY and net income was 144,067,000,000 JPY.
Operating cash flow was 716,344,000,000 JPY.
Get free Takeda Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,263,762,000,000 JPY
- Operating income
- 214,075,000,000 JPY
- Net income
- 144,067,000,000 JPY
- Operating cash flow
- 716,344,000,000 JPY